Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22035090 | 0.89 | CHRM2 (0.40) | CHRM2CHRM4CHRM3SMN1; SMN2CYP3A4 | |
| SCHEMBL12140495 | 0.85 | CA1 (0.47) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL30472587 | 0.85 | SLC6A2 (0.40) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL1934486 | 0.85 | SLC6A2 (0.40) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL30472636 | 0.85 | SLC6A2 (0.40) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL29315034 | 0.82 | HTT (0.43) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL2295236 | 0.81 | SLC6A2 (0.40) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL4135157 | 0.81 | CHRM2 (0.43) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL4135152 | 0.81 | CHRM2 (0.43) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 | |
| SCHEMBL4135155 | 0.81 | CHRM2 (0.43) | SLC6A2SLC6A4CHRM2CHRM4CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067379-B2 | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease | SCHERING CORPORATION (US) | 2011-11-29 | — | — | US | disclosed |
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | PRSS1, PRSS3, HPN | SLC6A2 3918/4885SLC6A4 2726/4885CHRM2 4856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.